Skip to main content
Clinical Trials/ACTRN12622001087741
ACTRN12622001087741
Recruiting
N/A

Assessing the usability and acceptability of a multiple health behavior change, self-monitoring mobile app for adolescents: A pilot trial of the Health4Life app

HMRC CTC0 sites75 target enrollmentAugust 5, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
poor diet
Sponsor
HMRC CTC
Enrollment
75
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HMRC CTC

Eligibility Criteria

Inclusion Criteria

  • 1\.Aged 13\-17 years
  • 2\.Living in Australia
  • 3\.Access to a smartphone
  • 4\.Willing to download the Health4Life app

Exclusion Criteria

  • 1\.Aged below 13 years or above 18 years
  • 2\.Not living in Australia
  • 3\.No access to a smartphone
  • 4\.Not willing or unable to download the Health4Life app
  • 5\.Insufficient English literacy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
The evaluation of usability, acceptability and immediate outcomes from the use of smartphone application for neck pain self-management in smartphone users with neck paieck painNeck painSmartphone applicationNeck pain self managementSelf managementAlternative therapy
TCTR20190124003Graduate School, Khon Kaen University100
Active, Not Recruiting
N/A
Evaluating the acceptability and usability of a digital self-management intervention (smartphone application) to support the non-surgical treatment of Perthes' DiseasePerthes' DiseaseMusculoskeletal Diseases
ISRCTN14517832niversity of Leeds30
Recruiting
N/A
Development of a website for family/friends of adults with depressioCarer mental healthDepressionMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - Depression
ACTRN12624000864527Deakin University30
Active, Not Recruiting
Phase 1
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiency
EUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S
Active, Not Recruiting
N/A
Evaluating the usability, acceptability and impact of a gamification/mindfulness etool for young peopleThe experience of stress & distress in young people.Mental Health - Other mental health disorders
ACTRN12615001001583Young and Well Cooperative Research Centre270